Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,610 | 16,590 | 9,110 | 11,730 | 9,680 |
| Marketable Securities | 0 | 0 | 0 | 0 | 4,900 |
| Receivables | 0 | 0 | 0 | 0 | 390 |
| Other current assets | 880 | 1,040 | 960 | 1,030 | 640 |
| TOTAL | $14,490 | $17,630 | $10,070 | $12,760 | $15,610 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 4,130 | 4,480 | 4,950 | 5,430 | 5,910 |
| TOTAL | $4,130 | $4,480 | $4,950 | $5,430 | $5,910 |
| Total Assets | $19,880 | $23,370 | $16,490 | $19,670 | $22,650 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 570 | 60 | 100 | 740 | 360 |
| Accrued Expenses | 1,330 | 950 | 990 | 850 | 1,180 |
| Other current liabilities | 0 | 0 | 250 | 500 | 750 |
| TOTAL | $2,200 | $2,030 | $2,370 | $3,110 | $3,310 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 510 | 0 |
| TOTAL | $260 | $350 | $430 | $510 | $560 |
| Total Liabilities | $2,470 | $2,380 | $2,800 | $3,630 | $3,880 |
| Shareholders' Equity | |||||
| Common Shares | 40 | 40 | 40 | 40 | 40 |
| Retained earnings | -133,340 | -129,680 | -127,130 | -124,770 | -122,030 |
| Other shareholders' equity | 0 | 0 | -10 | -20 | -20 |
| TOTAL | $17,410 | $20,990 | $13,690 | $16,040 | $18,760 |
| Total Liabilities And Equity | $19,880 | $23,370 | $16,490 | $19,670 | $22,640 |